Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are medications that lower blood sugar levels among other effects, provide kidney- and heart-related benefits to patients with and without diabetes. An exploratory ...
Nov 3, 2023
0
3
At the Hennepin Healthcare Center of Diabetes and Endocrinology in downtown Minneapolis, 66-year-old Mark Harris tries to recall his medication intake and sleep schedule from the past week.
Nov 1, 2023
0
1
In the first randomized clinical trial of its kind, a six-month produce prescription program significantly improved blood sugar control, food security and nutrition security among low-income adults enrolled in Medicaid with ...
Nov 7, 2023
0
5
People who have a higher biological age than their actual chronological age have a significantly increased risk of stroke and dementia, especially vascular dementia. These are the results of a study from Karolinska Institutet ...
Nov 5, 2023
0
23
There's good news for people with diabetes who are turning to drugs like Ozempic and Wegovy to treat their disease and lose weight: The drugs probably will not harm their vision.
Nov 9, 2023
0
0
More than 37 million people in the U.S. have diabetes. According to the American Diabetes Association, 8.4 million Americans needed to take insulin in 2022 to lower their blood sugar. Insulin, however, is tricky to deliver ...
Nov 15, 2023
0
28
A University of Alberta team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient's own stem cells, bringing the prospect of injection-free treatment closer for people ...
Nov 6, 2023
0
26
An experimental device that isolates blood flow to the brain has the potential to revolutionize brain research. The device redirects the brain's blood supply through a pump that maintains or adjusts a range of variables necessary ...
Nov 13, 2023
0
58
Sodium-glucose cotransporter-2 (SGLT2) inhibitors lower blood sugar levels and have additional beneficial effects on kidney and heart health for individuals with and without diabetes, but little is known about the safety ...
Nov 4, 2023
0
1
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have heart- and kidney-related benefits for patients with and without diabetes that go beyond their initial indication for lowering blood sugar levels. In clinical trials, ...
Nov 2, 2023
0
1
Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.
Mean normal blood glucose levels in humans are about 90 mg/100ml, equivalent to 5mM (mmol/l) (since the molecular weight of glucose, C6H12O6, is about 180 g/mol). The total amount of glucose normally in circulating human blood is therefore about 3.3 to 7g (assuming an ordinary adult blood volume of 5 litres, plausible for an average adult male). Glucose levels rise after meals for an hour or two by a few grams and are usually lowest in the morning, before the first meal of the day. Transported via the bloodstream from the intestines or liver to body cells, Glucose is the primary source of energy for body's cells, fats and oils (ie, lipids) being primarily a compact energy store.
Failure to maintain blood glucose in the normal range leads to conditions of persistently high (hyperglycemia) or low (hypoglycemia) blood sugar. Diabetes mellitus, characterized by persistent hyperglycemia from any of several causes, is the most prominent disease related to failure of blood sugar regulation.
This text uses material from Wikipedia, licensed under CC BY-SA
